Codes / ICD10CM / R70

R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Elevated Erythrocyte Sedimentation Rate and Abnormality of Plasma Viscosity

Summary

Elevated erythrocyte sedimentation rate (ESR) and abnormal plasma viscosity refer to increased rates of red blood cell settling and altered blood fluidity, respectively. These findings are nonspecific indicators of inflammation or other underlying processes. They may be transient or persistent and require clinical correlation to determine significance.

Causes

Elevated ESR and abnormal plasma viscosity can result from inflammatory conditions, infections, autoimmune disorders, or malignancies. Other potential causes include anemia, renal disease, or pregnancy. These changes may also occur in response to tissue injury or chronic diseases affecting blood composition.

Risk Factors

  • Underlying inflammatory or infectious conditions.
  • Autoimmune disorders (e.g., rheumatoid arthritis, lupus).
  • Malignancies or hematologic disorders.
  • Chronic kidney disease or anemia.
  • Advanced age or pregnancy.

Symptoms

  • No direct symptoms; findings are typically identified through laboratory testing.
  • Associated symptoms may reflect the underlying condition (e.g., fever, joint pain, fatigue).

Diagnosis

Diagnosis involves laboratory testing to measure ESR and plasma viscosity. Results are interpreted alongside clinical history, physical examination, and other diagnostic studies to identify underlying causes. Additional tests (e.g., C-reactive protein, complete blood count) may be ordered to narrow the differential.

Treatment Options

Treatment targets the underlying condition causing elevated ESR or abnormal plasma viscosity. This may include anti-inflammatory medications, antibiotics for infections, or disease-modifying therapies for autoimmune disorders. Management is guided by the specific etiology and patient symptoms.

Prognosis and Follow-Up

Prognosis depends on the underlying cause. Elevated ESR or abnormal plasma viscosity alone does not predict outcomes but serves as a marker for disease activity. Follow-up involves monitoring laboratory values and clinical status to assess response to treatment or progression of the underlying condition.

Complications

Complications may arise from the underlying disease process rather than the laboratory findings themselves. Persistent elevation could indicate uncontrolled inflammation or progression of a chronic condition, potentially leading to organ damage or systemic effects.

Lifestyle & Prevention

Lifestyle modifications focus on managing underlying conditions (e.g., diet, exercise for inflammatory disorders). Preventive measures include regular health screenings and adherence to prescribed treatments to reduce inflammation or disease activity.

When to Seek Professional Help

Seek medical attention if laboratory results are abnormal or if associated symptoms (e.g., unexplained fever, pain, fatigue) develop or worsen. Prompt evaluation is important to identify and address potential underlying causes.

Tips for Medical Coders

Document the clinical context and reason for testing (e.g., screening, evaluation of symptoms) to support code assignment. Ensure documentation links the findings to the patient's overall clinical picture, as these are nonspecific indicators requiring correlation with other data.

Book a walkthrough

R70 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.